Frazier Life Sciences Acquisition II Raises $78 Million in IPO and Private Placement

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Frazier Life Sciences Acquisition II raised $75 million in its IPO and $3 million in a concurrent private placement, with $75 million deposited in a trust account.

Key Highlights:

  • The October 15 IPO sold 7.5 million Class A shares at $10 each, generating $75 million in gross proceeds.
  • The sponsor purchased 300,000 private placement shares at $10 each, generating an additional $3 million.
  • A total of $75 million was placed in a U.S.-based trust account for the benefit of public shareholders.
  • The audited balance sheet reported $76.8 million in total assets, including $75 million in trust and $1.76 million in cash.
  • The company has not selected a business-combination target and reported no substantive discussions with potential targets.

Original SEC Filing: Frazier Life Sciences Acquisition Corp. II [ FLSC ] - 8-K - Oct. 22, 2026

Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Source: TradingView The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.